Abstract:BackgroundRecent studies have linked certain colibactin producing subphylas of E. coli to colorectal cancer. The bacterium synthesizes colibactin via the pks genomic island containing a series of clbA to clbS genes. The genotoxin causes inter-strand DNA cross-links, which lead to double strand breaks and promotion of colorectal adenocarcinoma. The published studies have prioritized the colorectal regions of the body where E. coli is commonly found, but none have identified the same genotoxic relationship with other types of adenocarcinoma. In this study, we evaluate DNA damage and cellular changes of mammary breast tissue based on high and low levels of colibactin producing E. coli exposure. The goal is to evaluate if colibactin can affect cells in the mammary breast tissue promoting breast adenocarcinoma growth.MethodsTwo cell lines were acquired from ATCC: primary mammary epithelial cells (PCS-600-010) and MCF-7 breast adenocarcinoma cells (HTB-22). Both cell lines were split into six culture flasks and maintained until ∼80% confluence was reached using the ATCC cell culture protocols. Once all the flasks had reached the target confluence, they were divided into exposure groups of high and low concentrations of colibactin producing E. coli, a group of non-colibactin producing E. coli, a group exposed only to phosphate buffered saline, and a control group with no exposure. Cellular morphology was observed using light microscopy before, after exposure, and every 5 minutes up to 15 minutes. E. coli and colibactin DNA concentrations were quantified using quantitative polymerase chain reaction. Genomic DNA was extracted from each group of cells. The DNA from each group was whole genome sequenced and analyzed for genomic variation.ResultsThe normal cells exposed to E. coli showed immediate lysing and continued to lyse after a 5 minute incubation; however, the adenocarcinoma positive cells showed no lysing up to 30 minutes incubation. Sequencing results show genomic variation between the groups and specific break points associated with the E. coli exposed groups.ConclusionsOur results show that the presence of E. coli with mammary breast tissue can destroy normal tissue, promote lysis resistance, and allow adenocarcinoma cells to continue to grow. The colibactin producing E. coli does cause double stranded breaks and can lead to cell death. This new information points out a critical need to monitor the microbiome and infection levels of people at risk or in early stages of cancer to prevent adenocarcinoma growth and destruction of normal tissue. This study indicates that colibactin producing E. coli may play a larger role in tissue damage and promotion of other types of cancer. More research is needed to elucidate the molecular pathway and mechanisms of colibactin, which will lead to new diagnostics or therapeutics that monitor E. coli levels or inhibit colibactin's toxic effects.

ClbR Is the Key Transcriptional Activator of Colibactin Gene Expression in Escherichia coli

L-tryptophan and copper interactions linked to reduced colibactin genotoxicity in pks+ Escherichia coli

Comparative Metabolomics and Structural Characterizations Illuminate Colibactin Pathway-Dependent Small Molecules

Genetic Structure and Distribution of the Colibactin Genomic Island among Members of the Family Enterobacteriaceae

Evolution of Polymyxin Resistance Regulates Colibactin Production in Escherichia coli

clbP Gene, a Potential New Member of the β-Lactamase Family

Colibactin leads to a bacteria-specific mutation pattern and self-inflicted DNA damage

Colibactin-driven colon cancer requires adhesin-mediated epithelial binding

Colibactin in avian pathogenic Escherichia coli contributes to the development of meningitis in a mouse model

ClbG in Avian Pathogenic Escherichia coli Contributes to Meningitis Development in a Mouse Model

B-351 Genotoxic Producing Escherichia coli Protects and Promotes Breast Adenocarcinoma

The quorum sensing peptide BlpC regulates the transcription of genes outside its associated gene cluster and impacts the growth of Streptococcus thermophilus

Intracellular effectors regulating the activity of the Lactococcus lactis CodY pleiotropic transcription regulator

The colibactin-producing Escherichia coli alters the tumor microenvironment to immunosuppressive lipid overload facilitating colorectal cancer progression and chemoresistance

Fecal carriage of colibactin encoding Escherichia coli associated with colorectal cancer among a student populace

Amount of Colicin Release in Escherichia coli Is Regulated by Lysis Gene Expression of the Colicin E2 Operon

Mother-to-infant transmission of the carcinogenic colibactin-producing bacteria

Oligosaccharides increase the genotoxic effect of colibactin produced by pks+ Escherichia coli strains

Colibactin-induced damage in bacteria is cell contact independent

Colibrimycins, Novel Halogenated Hybrid Polyketide Synthase-Nonribosomal Peptide Synthetase (PKS-NRPS) Compounds Produced by Streptomyces sp. Strain CS147

CsrA and its regulators control the time-point of ColicinE2 release in Escherichia coli